582 related articles for article (PubMed ID: 27273328)
1. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents.
Tsatsos M; MacGregor C; Athanasiadis I; Moschos MM; Hossain P; Anderson D
Clin Exp Ophthalmol; 2016 Dec; 44(9):824-837. PubMed ID: 27273328
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of herpes virus helicase-primase inhibitor, ASP2151, for treating herpes simplex keratitis in mouse model.
Sasaki S; Miyazaki D; Haruki T; Yamamoto Y; Kandori M; Yakura K; Suzuki H; Inoue Y
Br J Ophthalmol; 2013 Apr; 97(4):498-503. PubMed ID: 23361434
[TBL] [Abstract][Full Text] [Related]
3. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
Itahashi M; Higaki S; Shimomura Y
Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus keratitis after laser in situ keratomileusis.
Levy J; Lapid-Gortzak R; Klemperer I; Lifshitz T
J Refract Surg; 2005; 21(4):400-2. PubMed ID: 16128340
[TBL] [Abstract][Full Text] [Related]
5. Effects of antiviral medications on herpetic epithelial keratitis in mice.
Komoto S; Higaki S; Fukuda M; Shimomura Y
Jpn J Ophthalmol; 2015 May; 59(3):194-200. PubMed ID: 25707352
[TBL] [Abstract][Full Text] [Related]
6. Modalities to decrease stromal herpes simplex keratitis reactivation rates.
Weisberg MP; Sugar J
Arch Ophthalmol; 2010 Nov; 128(11):1497; author reply 1497-8. PubMed ID: 21060060
[No Abstract] [Full Text] [Related]
7. Comparison of efficacy of oral valacyclovir and topical acyclovir in the treatment of herpes simplex keratitis: a randomized clinical trial.
Sozen E; Avunduk AM; Akyol N
Chemotherapy; 2006; 52(1):29-31. PubMed ID: 16340195
[TBL] [Abstract][Full Text] [Related]
8. Effect of oral valaciclovir on herpetic keratitis.
Higaki S; Itahashi M; Deai T; Fukuda M; Shimomura Y
Cornea; 2006 Dec; 25(10 Suppl 1):S64-7. PubMed ID: 17001196
[TBL] [Abstract][Full Text] [Related]
9. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
[TBL] [Abstract][Full Text] [Related]
10. Development of Herpes Simplex Virus Infectious Epithelial Keratitis During Oral Acyclovir Therapy and Response to Topical Antivirals.
Carter SB; Cohen EJ
Cornea; 2016 May; 35(5):692-5. PubMed ID: 26989961
[TBL] [Abstract][Full Text] [Related]
11. Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study.
Rousseau A; Boutolleau D; Titier K; Bourcier T; Chiquet C; Weber M; Colin J; Gueudry J; M'Garrech M; Bodaghi B; Burrel S; Agut H; Deback C; ; Labetoulle M
Antiviral Res; 2017 Oct; 146():205-212. PubMed ID: 28939476
[TBL] [Abstract][Full Text] [Related]
12. Topical interferon alpha-2a treatment of herpes simplex keratitis resistant to multiple antiviral medications in an immunosuppressed patient.
Minkovitz JB; Pepose JS
Cornea; 1995 May; 14(3):326-30. PubMed ID: 7600820
[TBL] [Abstract][Full Text] [Related]
13. Treatment of herpetic keratitis with acyclovir: benefits and problems.
Ohashi Y
Ophthalmologica; 1997; 211 Suppl 1():29-32. PubMed ID: 9065935
[TBL] [Abstract][Full Text] [Related]
14. Modalities to decrease stromal herpes simplex keratitis reactivation rates.
Sheppard JD; Wertheimer ML; Scoper SV
Arch Ophthalmol; 2009 Jul; 127(7):852-6. PubMed ID: 19597103
[TBL] [Abstract][Full Text] [Related]
15. Oral acyclovir for the management of herpes simplex virus keratitis in children.
Schwartz GS; Holland EJ
Ophthalmology; 2000 Feb; 107(2):278-82. PubMed ID: 10690825
[TBL] [Abstract][Full Text] [Related]
16. Pediatric herpes simplex virus keratitis.
Hsiao CH; Yeung L; Yeh LK; Kao LY; Tan HY; Wang NK; Lin KK; Ma DH
Cornea; 2009 Apr; 28(3):249-53. PubMed ID: 19387223
[TBL] [Abstract][Full Text] [Related]
17. Archipelago keratitis: a clinical variant of recurrent herpetic keratitis?
Gabison EE; Alfonsi N; Doan S; Racine L; Sultan G; Baudouin C; Hoang-Xuan T
Ophthalmology; 2007 Nov; 114(11):2000-5. PubMed ID: 17418418
[TBL] [Abstract][Full Text] [Related]
18. Valacyclovir inhibition of recovery of ocular herpes simplex virus type 1 after experimental reactivation by laser in situ keratomileusis.
Dhaliwal DK; Romanowski EG; Yates KA; Hu D; Mah FS; Fish DN; Gordon YJ
J Cataract Refract Surg; 2001 Aug; 27(8):1288-93. PubMed ID: 11524202
[TBL] [Abstract][Full Text] [Related]
19. Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis.
Colin J; Hoh HB; Easty DL; Herbort CP; Resnikoff S; Rigal D; Romdane K
Cornea; 1997 Jul; 16(4):393-9. PubMed ID: 9220235
[TBL] [Abstract][Full Text] [Related]
20. Aciclovir-resistant herpes keratitis.
Choong K; Walker NJ; Apel AJ; Whitby M
Clin Exp Ophthalmol; 2010 Apr; 38(3):309-13. PubMed ID: 20447128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
